Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
Determining the effect of Persian medicine products on O2 saturation in patients with or suspected of COVID-19
Determining the Effect of Persian medicine products on Respiratory Rate in Patients With or Suspected of COVID-19
The effect of Persian medicine products on CRP levels of patients with or suspected of COVID-19
The effect of Persian medicine products on lymphocyte levels in patients with or suspected of COVID-19
Determining the effect of Persian medicine products on WBC levels in patients with or suspected of COVID-19
Design:
A randomized clinical trial with two group: control and intervention
Settings and conduct:
The study will be conducted at Imam Reza Hospital. Patients will be randomly divided into intervention and control groups. Given the open-label study, Blinding will not happen.
Participants/Inclusion and exclusion criteria:
Patients over 18 years old hospitalized with or suspected of COVID-19: Liver, kidney and heart failure, Immunodeficiency, Pregnancy and breast feeding, Hypertension, Alcohol or drug addiction, A history of allergies to medicinal herbs, Patients with transplanted organs, Cor Pulmonel Patients, History of deep vein thrombosis
Intervention groups:
Intervention group: standard treatment, Persian medicine capsule, Persian medicine syrup
Control group: standard treatment
Main outcome variables:
Oxygen saturation: Respiratory Rate